Nethanel Asher

12PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Oral implantologyCancer diagnosisImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 27, 2026
Vulvar and Vaginal Melanoma: Real-world Clinical Outcomes and Prognostic Differences From a Single-center Experience.

|Nov 10, 2024
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases.

Danielle K DePalo, Michelle M Dugan, Syeda Mahrukh Hussnain Naqvi

|Nov 15, 2023
Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach.

Shirly Grynberg, Marilena Vered, Ronnie Shapira-Frommer

|Sep 28, 2023
The Implications of a Dermatopathologist's Report on Melanoma Diagnosis and Treatment.

Asher Nethanel, Christofis Kyprianou, Aviv Barzilai

|Aug 31, 2023
Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Melanoma.

Jack Pepys, Ronen Stoff, Roni Ramon-Gonen

|Jun 10, 2023
Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with Immunotherapy.

Neta Bar-Hai, Guy Ben-Betzalel, Ronen Stoff

Pageof 2

Frequent Collaborators

4 joint publications

Ronnie Shapira-Frommer

3 joint publications

Ronen Stoff

2 joint publications

Michal J Besser

2 joint publications

Guy Ben-Betzalel